WO2020256297A1 - Anti-aging composition comprising albatrellus confluens, and preparation method for same - Google Patents
Anti-aging composition comprising albatrellus confluens, and preparation method for same Download PDFInfo
- Publication number
- WO2020256297A1 WO2020256297A1 PCT/KR2020/006778 KR2020006778W WO2020256297A1 WO 2020256297 A1 WO2020256297 A1 WO 2020256297A1 KR 2020006778 W KR2020006778 W KR 2020006778W WO 2020256297 A1 WO2020256297 A1 WO 2020256297A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- albatrellus
- mushroom
- aging
- composition
- powder
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 230000003712 anti-aging effect Effects 0.000 title claims description 23
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 241001199091 Albatrellus confluens Species 0.000 title description 32
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 11
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 10
- 230000032683 aging Effects 0.000 claims abstract description 7
- 230000037394 skin elasticity Effects 0.000 claims abstract description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 59
- 239000000284 extract Substances 0.000 claims description 39
- 239000000843 powder Substances 0.000 claims description 35
- 238000000855 fermentation Methods 0.000 claims description 17
- 230000004151 fermentation Effects 0.000 claims description 17
- 240000000249 Morus alba Species 0.000 claims description 14
- 235000008708 Morus alba Nutrition 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 10
- 239000000469 ethanolic extract Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 5
- 241000993279 Albatrellus ovinus Species 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 230000008591 skin barrier function Effects 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 241000959647 Albatrellus Species 0.000 claims description 3
- 241000014829 Albatrellus caeruleoporus Species 0.000 claims description 3
- 241000643942 Albatrellus cristatus Species 0.000 claims description 3
- 241000409065 Albatrellus dispansus Species 0.000 claims description 3
- 241001599308 Albatrellus ellisii Species 0.000 claims description 3
- 241001199085 Albatrellus pes-caprae Species 0.000 claims description 3
- 241001420287 Strobilanthes maculata Species 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 230000014759 maintenance of location Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 2
- 102000003566 TRPV1 Human genes 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 abstract description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 9
- 235000013824 polyphenols Nutrition 0.000 abstract description 9
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 8
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 abstract description 8
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 8
- 230000009759 skin aging Effects 0.000 abstract description 7
- 231100000135 cytotoxicity Toxicity 0.000 abstract description 6
- 230000003013 cytotoxicity Effects 0.000 abstract description 6
- PZHNKNRPGLTZPO-VZRGJMDUSA-N Grifolin Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC1=C(O)C=C(C)C=C1O PZHNKNRPGLTZPO-VZRGJMDUSA-N 0.000 abstract description 5
- PZHNKNRPGLTZPO-UHFFFAOYSA-N Grifolin Natural products CC(C)=CCCC(C)=CCCC(C)=CCC1=C(O)C=C(C)C=C1O PZHNKNRPGLTZPO-UHFFFAOYSA-N 0.000 abstract description 5
- 230000004941 influx Effects 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 4
- 101150016206 Trpv1 gene Proteins 0.000 abstract description 3
- 230000004913 activation Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 23
- 210000003491 skin Anatomy 0.000 description 20
- 239000000243 solution Substances 0.000 description 15
- 108050004388 Transient receptor potential cation channel subfamily V member 1 Proteins 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 10
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000017663 capsaicin Nutrition 0.000 description 5
- 229960002504 capsaicin Drugs 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000037351 starvation Effects 0.000 description 3
- 238000001931 thermography Methods 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- 101000633069 Homo sapiens Transient receptor potential cation channel subfamily V member 1 Proteins 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 102100029613 Transient receptor potential cation channel subfamily V member 1 Human genes 0.000 description 2
- DRCMAZOSEIMCHM-UHFFFAOYSA-N capsazepine Chemical compound C1C=2C=C(O)C(O)=CC=2CCCN1C(=S)NCCC1=CC=C(Cl)C=C1 DRCMAZOSEIMCHM-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000010200 folin Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 238000002954 Fluo-8 No Wash Calcium Assay Kit Methods 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Definitions
- the present invention relates to an antioxidant composition with improved content of an active ingredient and a method for manufacturing the same, and to an anti-aging composition for inhibiting aging due to environments such as heat and moisture, and a method for manufacturing the same.
- Skin is largely divided into three layers: epidermis, dermis, and subcutaneous fat tissue in order from the outside, and functions to protect the human body from physical and chemical stimulation by the external environment.
- the skin carries about 65-70% of the moisture that the human body has, that is, various physiologically active substances necessary for the human body, and it is important to control the evaporation of this moisture to the outside of the body, helping to keep the skin soft and moist. Plays a role.
- the condition of the skin is aging due to various causes such as changes in the external environment or changes in life patterns, artificial temperature control of cooling/heating, solar heat or sunlight, various stresses generated in social life and skin stress caused by environmental pollution. Is promoted.
- ingredients such as mint and menthol can cause unpleasant sensations such as pain when applied near the eyes, and erythritol can cause allergies when applied to the skin, and can cause gastrointestinal disorders when taken. .
- It provides a method for producing an anti-aging composition comprising a fermented mulberry mushroom comprising the step of centrifuging and filtering the sterilized fermentation powder to obtain a supernatant.
- the composition comprises fermented or non-fermented woolly shield mushroom ( Albatrellus ovinus (Schaeff.) Kotl. & Pouz.), flower shield mushroom ( Albatrellus dispansus (Lloyd) Canf. & Gilb.), green shield mushroom. ( Albatrellus caeruleoporus (Peck) Pouz.), gray-blue shield mushroom ( Albatrellus yasudae (Lloyd) Pouzar), long legs shield mushroom ( Albatrellus pes- caprae), Albatrellus cristatus and one or more extracts selected from the group consisting of Albatrellus ellisii . can do.
- Albatrellus ovinus (Schaeff.) Kotl. & Pouz.)
- flower shield mushroom Albatrellus dispansus (Lloyd) Canf. & Gilb.
- green shield mushroom Albatrellus caeruleoporus (Peck) Pouz.
- It can be prepared by a method comprising the step of sequentially producing a powder by concentration.
- the anti-aging may include one or more uses selected from the group consisting of anti-heat aging, skin elasticity, skin barrier protection, antioxidant, moisture retention, and antibacterial.
- a cosmetic composition containing the anti-aging composition as described above.
- the present invention provides a health functional food composition containing the anti-aging composition as described above.
- the present invention can solve the disadvantages of the conventional anti-aging composition by providing a composition having an increased content of an active ingredient for anti-aging.
- a composition that minimizes irritation in the skin and the body and improves the anti-aging effect, it can be usefully used as an external preparation for skin, a cosmetic composition, a functional food composition, and the like.
- 1 is a graph showing the polyphenol content.
- 3 is a graph showing the cytotoxicity results.
- 5 is a graph showing the degree of MMP-1 gene expression.
- FIG. 6 is a graph showing the level of expression of the TRPV1 gene.
- 9 and 10 are graphs showing the results of HPLC analysis of grifolin.
- the composition according to the invention is for suppressing skin aging, in particular skin aging due to heat.
- a protein TRPV1 The transient receptor potential cation channel subfamily V member 1
- the composition of the present invention regulates the activity of these proteins to prevent skin damage caused by thermal stimulation and evaporate moisture Can be suppressed.
- the composition according to the present invention may include a mushroom fermented product.
- Mushrooms used in the mushroom fermentation can be used in the genus Shield Mushroom, and specific examples include Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.), Wool Shield Mushroom ( Albatrellus ovinus (Schaeff.) Kotl.& Pouz.), flower shield mushroom ( Albatrellus dispansus (Lloyd) Canf.
- Albatrellus cristatus may contain one or more selected from the group consisting of Albatrellus ellisii , fermented or non-fermented ones may be used.
- it may include a bundle of shield mushrooms, a wool shield mushroom, or a combination thereof. Multiple shield mushrooms or woolly shield mushrooms can play a role in antioxidant, anti-aging, and inhibition of TRPV1 activity.
- the mushroom fermentation product may be fermented by enzymes or yeast, for example, germinating yeast, that is, mushrooms fermented by Saccharomyces cerevisiae (Budding yeast; Saccharomyces cerevisiae ) It may be a fermented product.
- germinating yeast that is, mushrooms fermented by Saccharomyces cerevisiae (Budding yeast; Saccharomyces cerevisiae ) It may be a fermented product.
- the mushroom fermentation product is the mushroom fermentation product
- It can be prepared by a method comprising the step of obtaining a supernatant by centrifuging the sterilized fermented powder liquid at 6000 rpm for 20 minutes and then filtering 0.2um.
- fatty acids such as oleic acid and linoleic acid, magnesium (Mg), zinc (Zn), minerals such as copper (Cu), and
- Mg magnesium
- Zn zinc
- Cu copper
- gripholine in particular, regulates a temperature receptor called TRPV1 (transient receptor potential cation channel subfamily V member 1) to inhibit aging due to an increase in the temperature of the skin, plays an anti-inflammatory and anti-cancer role, and is thus produced by the method according to the present invention.
- Mushroom fermentations containing foline can be prepared.
- the shield mushroom ethanol extract
- It can be prepared by a method comprising the step of producing a powder by concentration in sequence.
- the shield mushroom extract may be added at any stage of the manufacturing step of the shield mushroom fermentation product, but, for example, when added at the stage before strain inoculation, which is the initial stage of fermentation, the polyphenol content and efficacy may be increased through fermentation.
- composition of the present invention prepared by the method as described above can improve the anti-aging effect, the anti-aging effect is one selected from the group consisting of anti-heat aging, skin elasticity, skin barrier protection, antioxidant, moisture retention and antibacterial It may include more than one.
- Albatrellus confluens ( Albatrellus confluens , Finnish water supply, powder) was used. Distilled water in an amount corresponding to 20 times the weight of the mulberry powder was added, mixed, and stirred to prepare a powder solution. The powder was sterilized at 121° C. for 15 minutes to pre-ferment.
- the mulberry ethanol extract was added with 70% ethanol of 10 times the weight of the mulberry powder, stirred at 45° C. for 3 hours, centrifuged at 6000 rpm for 20 minutes, filtered with 0.45 um, filtered mulberry ethanol The extract was concentrated to prepare a powder.
- the fermented powder was sterilized at 121° C. for 15 minutes, centrifuged at 6000 rpm for 20 minutes, and then filtered with 0.2 ⁇ m to obtain a supernatant as a fermented mushroom.
- the properties of the obtained fermented mushroom are as follows.
- distilled water in an amount corresponding to 20 times the weight thereof was added to Albatrellus confluens (Finnish water supply, powder), and mixed and stirred to prepare a powder solution.
- the powder solution was centrifuged at 6000 rpm for 20 minutes and filtered with 0.2 ⁇ m after centrifugation at 6000 rpm for 20 minutes by adding 1% of 70% ethanol extract prepared in the same manner to the hot water extract sterilized at 121°C for 15 minutes.
- the extract was prepared.
- the absorbance was measured at 750 nm using the absorbance measuring instrument Multiskan GO (Thermo Fisher Scientific), and the amount of total polyphenol before and after fermentation was compared with the absorbance value of the standard material.
- the results are shown in Fig. 1, and as shown in Fig. 1, it can be seen that the mushroom fermented product included in the present invention has a total polyphenol content increased by about 25% compared to the non-fermented fermented extract.
- DPPH (2,2-diphenyl-1-picryl hydrezyl) to confirm the antioxidant and effect of the Albatrellus confluens extract according to the comparative example and the Albatrellus confluens ferment extract according to the example Radical scavenging ability analysis was performed.
- 1 mM DPPH solution was dissolved in methanol and used immediately.
- the sample solution and the DPPH solution were mixed at a ratio of 1:1, and left in the dark at room temperature for 20 minutes. At this time, 0.1 mg/ml of ascorbic acid was used as a positive control.
- absorbance was measured at 540 nm using an absorbance measuring instrument Multiskan GO (Thermo Fisher Scientific).
- the radical ratio (%) compared to the control group (control) was calculated.
- the results are shown in Fig. 2, and as shown in the graph, it can be seen that the antioxidant efficacy of Albatrellus confluens ferment extract is higher than that of the sample before fermentation, especially at a concentration of 1000 ug/ml of the fermented product. It was confirmed that 80% of the free radical scavenging ability was shown.
- the effect on the proliferation of HaCaT keratinocytes was tested, and the cultured HaCaT keratinocytes were treated with Albatrellus confluens ferment extract and Albatrellus confluens extract at respective concentrations, and then cell viability was measured.
- MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was measured using a reagent, and MTT was absorbed into cells to form formazan by succinate dehydratase in mitochondria. Accumulation of substances in cells means mitochondrial activity, broadly, cellular activity, so the toxicity of cells can be evaluated.
- Each cell was aliquoted into a 96 well plate at 2 X 10 4 cells/well and cultured in a cell incubator for 24 hours. After cultivation, the medium was replaced with a medium containing 1% FBS, resulting in starvation and cultured for 24 hours. Albatrellus confluens extract and Albatrellus confluens ferment extract were treated at respective concentrations and cultured for 24 hours, followed by treatment with MTT solution and cultured for 4 hours. After cultivation, the medium was removed and the cells were completely dissolved with dimethyl sulfoxide (DMSO), and absorbance was measured at 450 nm with an absorbance measuring instrument Multiskan GO (Thermo Fisher Scientific). Based on the results, the cell viability was expressed as% by comparing the cell viability with the group not treated with the sample through the formula for calculating the cell viability below.
- DMSO dimethyl sulfoxide
- Cell viability (%) [absorbance of the sample added group (450 nm) / absorbance of the sample-free group (450 nm)] ⁇ 100
- TRPV1 is activated by the detection of thermal or chemical stimulation to induce the influx of calcium (Ca 2+ ) into the cell, which induces cell senescence. Therefore, the degree of cell aging was confirmed by checking the influx of calcium.
- TRPV1 The transient receptor potential cation channel, subfamily V, member 1
- stimulation such as temperature above 42°C, capsaicin, and acidic conditions
- TRPV1 The transient receptor potential cation channel, subfamily V, member 1
- the degree of activity of TRPV1 can be confirmed by checking the change in calcium ion in the cell.
- Each cell was aliquoted into a 96 well plate at 1 X 10 4 cells/well and incubated in a cell incubator for 24 hours. After cultivation, the medium was replaced with a medium containing 1% FBS, resulting in starvation and cultured for 24 hours. Albatrellus confluens ferment extract and Albatrellus confluens extract were treated according to the concentration and incubated for 30 minutes. At this time, 5 ⁇ M capsazepine was used as a control. Calcium Kit; The loading solution was treated with Fluo-8 No wash Calcium Assay Kit (abcam), and incubated for 30 minutes at 37°C and 30 minutes at room temperature in dark conditions.
- abcam Fluo-8 No wash Calcium Assay Kit
- Albatrellus confluens ferment extract and Albatrellus confluens extract express mRNA of TRPV1 (The transient receptor potential cation channel, subfamily V, member 1) and MMP-1 (Matrix metalloproteinase-1).
- TRPV1 The transient receptor potential cation channel, subfamily V, member 1
- MMP-1 Microx metalloproteinase-1.
- An experiment was conducted to check whether the amount was controlled. After dispensing 1 X 10 6 cells/well into a 6 well plate, it was cultured in a cell incubator for 24 hours. After cultivation, the medium was replaced with a medium containing 1% FBS, resulting in starvation and cultured for 24 hours.
- Albatrellus confluens ferment extract and Albatrellus confluens extract were treated according to the concentration and incubated for 30 minutes.
- RNA extract kit (TaKaRa MiniBest RNA Extraction Kit)
- RNA was quantified using a Qubit Fluorometer (Qubit 2.0 Fluorometer, life technologies).
- CDNA was synthesized with the same amount of RNA using a High-Capacity RNA-to-cDNA kit (applied biosystems).
- Taqman primers TRPV1, MMP-1, and GAPDH were purchased and used from life technologies.
- FIG. 7 shows the amount of change in the temperature of the stratum corneum before and after the application of the cream containing the fermented mulberry mushroom according to the embodiment, and as can be seen from the graph, an average 2.63°C skin temperature reduction effect at the test site is shown. Can be seen.
- a measurement photograph of the thermal imaging camera is shown in FIG. 8, and a temperature change of the left cheek, which is a test area to which the fermentation product according to the embodiment is applied, can be confirmed.
- the standard analysis peak of gripholine is shown in Fig. 9, and the results of the multi-leaf mushroom ferment (Albatrellus ovinus ferment extract) are shown in Fig. 10.
- the mushroom fermented product according to the present invention contained gripholine.
- a composition containing active ingredients such as griffoline and polyphenol can be obtained, antioxidant efficacy can be improved without cytotoxicity, and calcium ions can enter cells
- active ingredients such as griffoline and polyphenol
- antioxidant efficacy can be improved without cytotoxicity
- calcium ions can enter cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an antioxidant composition for inhibiting aging induced by the environment, such as heat and humidity, and to a preparation method for the composition. According to the present invention: a composition comprising effective components such as grifolin and polyphenols can be obtained; antioxidant effects can be enhanced without cytotoxicity; skin aging and a decrease in skin elasticity can be prevented by inhibiting the influx of calcium ions into cells, thereby inhibiting TRPV1 and MMP-1 activation; and skin aging can be inhibited more effectively by improving an immediate skin cooling effect.
Description
본 발명은 유효성분의 함량을 향상시킨 항산화 조성물 및 그 제조방법에 관한 것으로, 열, 수분 등의 환경으로 인한 노화를 억제하기 위한 항노화 조성물 및 그 제조방법에 관한다.The present invention relates to an antioxidant composition with improved content of an active ingredient and a method for manufacturing the same, and to an anti-aging composition for inhibiting aging due to environments such as heat and moisture, and a method for manufacturing the same.
본 출원은 2019.06.18.자 한국 특허 출원 제2019-0072250호에 기초한 우선권의 이익을 주장하며, 해당 한국 특허 출원의 문헌에 개시된 모든 내용은 본 명세서의 일부로서 포함된다. This application claims the benefit of priority based on Korean Patent Application No. 2019-0072250 filed on June 18, 2019, and all contents disclosed in the documents of the Korean patent application are included as part of this specification.
피부는 외부에서부터 순서대로 표피, 진피 및 피하지방 조직의 3개 층으로 크게 구분되며, 외부 환경에 의한 물리적, 화학적인 자극으로부터 인체를 보호해 주는 기능을 한다. 특히 피부는 인체가 가지고 있는 약 65~70%의 수분, 즉 인체에 필요한 각종 생리 활성 물질을 운반하며, 피부가 부드럽고 촉촉한 상태를 유지할 수 있도록 도와주는 이러한 수분이 체외로 증발되는 것을 조절해 주는 중요한 역할을 한다.Skin is largely divided into three layers: epidermis, dermis, and subcutaneous fat tissue in order from the outside, and functions to protect the human body from physical and chemical stimulation by the external environment. In particular, the skin carries about 65-70% of the moisture that the human body has, that is, various physiologically active substances necessary for the human body, and it is important to control the evaporation of this moisture to the outside of the body, helping to keep the skin soft and moist. Plays a role.
피부의 상태는 외부 환경의 변화 혹은 생활 패턴의 변화, 냉/난방의 인위적인 온도 조절, 태양열 또는 태양광, 사회 생활에서 발생되는 각종 스트레스와 환경 오염으로 인한 피부 스트레스 등의 여러 가지 원인으로 인하여 노화가 촉진된다.The condition of the skin is aging due to various causes such as changes in the external environment or changes in life patterns, artificial temperature control of cooling/heating, solar heat or sunlight, various stresses generated in social life and skin stress caused by environmental pollution. Is promoted.
피부의 노화 원인 중, 열 자극에 의한 손상을 방지하기 위하여 종래에는 피부의 온도를 저하시키려는 노력을 하고 있다. 이러한 피부 표면 쿨링의 목적으로 종래의 제품은 민트(mint), 멘톨(menthol), 에리스리톨(erythritol) 등의 성분을 함유하는 조성물을 사용하고 있다.Among the causes of skin aging, efforts have been made to lower the temperature of the skin in the prior art in order to prevent damage caused by thermal stimulation. For the purpose of cooling the skin surface, conventional products use a composition containing components such as mint, menthol, and erythritol.
그러나, 민트, 멘톨과 같은 성분은 눈가 근처에 적용 시 동통 등의 불쾌한 감각을 유발할 수 있으며, 에리스리톨은 피부에 적용 시 알러지를 유발할 수 있으며, 복용 시 위장장애를 유발할 수 있다는 증례가 보고된 바 있다.However, it has been reported that ingredients such as mint and menthol can cause unpleasant sensations such as pain when applied near the eyes, and erythritol can cause allergies when applied to the skin, and can cause gastrointestinal disorders when taken. .
이에 따라, 피부 및 체내에 자극을 최소화하면서 항노화 효과를 향상시키기 위한 조성물에 관한 연구가 요구된다.Accordingly, there is a need for a study on a composition for improving the anti-aging effect while minimizing irritation in the skin and body.
본 발명의 목적은 항노화 조성물을 제공하는 것이다.It is an object of the present invention to provide an anti-aging composition.
또한, 상기 조성물의 제조방법을 제공하는 것이다.In addition, it is to provide a method for preparing the composition.
상기 과제를 해결하기 위하여, 본 발명은In order to solve the above problems, the present invention
다발방패버섯(
Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.) 분말에 20배 중량의 증류수를 첨가하고 혼합 및 교반하여 분말액을 제조하는 단계;Adding 20 times the weight of distilled water to the powder of Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.), mixing and stirring to prepare a powder solution;
상기 분말액을 110 내지 130℃에서 10 내지 20분 동안 멸균하여 열수추출하는 단계;Sterilizing the powder solution at 110 to 130° C. for 10 to 20 minutes to extract hot water;
멸균하여 열수추출한 분말액 100중량부에 대하여, 다발방패버섯 에탄올 추출물 1중량부를 추가하고, 영양배지(YM broth, BD)에서 24시간 동안 배양한 사카로미세스 세레비시아(
Saccharomyces cerevisiae, 생물자원센터, KCTC 7296) 5중량부를 접종하여 25 내지 35℃에서 60 내지 80시간 동안 발효하는 단계;To 100 parts by weight of sterilized and hot water-extracted powder solution, 1 part by weight of ethanol extract of mulberry mushroom was added, and Saccharomyces cerevisiae cultured in a nutrient medium (YM broth, BD) for 24 hours ( Saccharomyces cerevisiae , Center for Biological Resources) , KCTC 7296) 5 parts by weight of inoculation and fermentation at 25 to 35°C for 60 to 80 hours;
발효된 분말액을 110 내지 130℃에서 10 내지 20분 동안 멸균하는 단계; 및Sterilizing the fermented powder liquid at 110 to 130° C. for 10 to 20 minutes; And
멸균된 발효 분말액을 원심분리 및 필터하여 상등액을 수득하는 단계를 포함하는 다발방패버섯 발효물을 포함하는 항노화 조성물의 제조방법을 제공한다.It provides a method for producing an anti-aging composition comprising a fermented mulberry mushroom comprising the step of centrifuging and filtering the sterilized fermentation powder to obtain a supernatant.
일구현예에 따르면, 상기 조성물은 발효 또는 비발효된 양털방패버섯(
Albatrellus ovinus (Schaeff.) Kotl. & Pouz.), 꽃방패버섯(
Albatrellus dispansus (Lloyd) Canf. & Gilb.), 초록방패버섯(
Albatrellus caeruleoporus (Peck) Pouz.), 회청색방패버섯(
Albatrellus yasudae (Lloyd) Pouzar), 긴다리방패버섯(
Albatrellus pes-caprae),
Albatrellus cristatus 및
Albatrellus ellisii으로 이루어지는 군으로부터 선택되는 하나 이상의 추출물을 더 포함할 수 있다.According to an embodiment, the composition comprises fermented or non-fermented woolly shield mushroom ( Albatrellus ovinus (Schaeff.) Kotl. & Pouz.), flower shield mushroom ( Albatrellus dispansus (Lloyd) Canf. & Gilb.), green shield mushroom. ( Albatrellus caeruleoporus (Peck) Pouz.), gray-blue shield mushroom ( Albatrellus yasudae (Lloyd) Pouzar), long legs shield mushroom ( Albatrellus pes- caprae), Albatrellus cristatus and one or more extracts selected from the group consisting of Albatrellus ellisii . can do.
일구현예에 따르면, 상기 다발방패버섯 에탄올 추출물은According to an embodiment, the ethanol extract of mulberry mushroom
방패버섯 분말의 10배 중량의 70% 에탄올을 첨가하는 단계;Adding 70% ethanol of 10 times the weight of the shield mushroom powder;
30 내지 50℃에서 2 내지 4시간 동안 교반하는 단계;Stirring at 30 to 50° C. for 2 to 4 hours;
6000rpm으로 20분간 원심분리 후 0.45um로 여과하는 단계; 및Centrifuging at 6000rpm for 20 minutes and then filtering with 0.45um; And
농축하여 분말로 제조하는 단계를 순차적으로 포함하는 방법으로 제조될 수 있다.It can be prepared by a method comprising the step of sequentially producing a powder by concentration.
일구현예에 따르면, 상기 항노화가 항열노화, 피부 탄력, 피부장벽 보호, 항산화, 수분 유지 및 항균으로 이루어지는 군으로부터 선택되는 하나 이상의 용도를 포함할 수 있다.According to one embodiment, the anti-aging may include one or more uses selected from the group consisting of anti-heat aging, skin elasticity, skin barrier protection, antioxidant, moisture retention, and antibacterial.
본 발명의 다른 구현예에 따르면, 상기한 바와 같은 항노화 조성물을 함유하는 화장료 조성물을 제공한다.According to another embodiment of the present invention, there is provided a cosmetic composition containing the anti-aging composition as described above.
본 발명의 또 다른 구현예에 따르면, 상기한 바와 같은 항노화 조성물을 함유하는 건강 기능성 식품 조성물을 제공한다.According to another embodiment of the present invention, it provides a health functional food composition containing the anti-aging composition as described above.
기타 본 발명의 구현예들의 구체적인 사항은 이하의 상세한 설명에 포함되어 있다.Other specifics of the embodiments of the present invention are included in the detailed description below.
본 발명은 항노화를 위한 유효성분의 함량을 증가시킨 조성물을 제공함으로써 종래의 항노화 조성물의 단점을 해결할 수 있다. 피부 및 체내에서의 자극을 최소화하고, 항노화 효과를 향상시킨 조성물을 제공함으로써 피부 외용제, 화장료 조성물, 기능성 식품 조성물 등으로 유용하게 사용될 수 있다.The present invention can solve the disadvantages of the conventional anti-aging composition by providing a composition having an increased content of an active ingredient for anti-aging. By providing a composition that minimizes irritation in the skin and the body and improves the anti-aging effect, it can be usefully used as an external preparation for skin, a cosmetic composition, a functional food composition, and the like.
도 1은 폴리페놀 함량을 나타내는 그래프이다.1 is a graph showing the polyphenol content.
도 2는 DPPH 분석 결과를 나타내는 그래프이다.2 is a graph showing the DPPH analysis result.
도 3은 세포독성 결과를 나타내는 그래프이다.3 is a graph showing the cytotoxicity results.
도 4는 칼슘 유입 결과를 나타내는 그래프이다.4 is a graph showing the result of calcium inflow.
도 5는 MMP-1 유전자 발현 정도를 나타내는 그래프이다.5 is a graph showing the degree of MMP-1 gene expression.
도 6은 TRPV1 유전자 발현 정도를 나타내는 그래프이다.6 is a graph showing the level of expression of the TRPV1 gene.
도 7은 각질층의 온도 변화를 나타내는 그래프이다.7 is a graph showing the temperature change of the stratum corneum.
도 8은 열화상 카메라 측정 사진이다.8 is a photograph of the thermal imaging camera.
도 9 및 10은 그리폴린(grifolin)의 HPLC 분석 결과를 나타내는 그래프이다.9 and 10 are graphs showing the results of HPLC analysis of grifolin.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예를 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.Since the present invention can apply various transformations and have various embodiments, specific embodiments are illustrated in the drawings and will be described in detail in the detailed description. However, this is not intended to limit the present invention to a specific embodiment, it is to be understood to include all conversions, equivalents, and substitutes included in the spirit and scope of the present invention. In describing the present invention, when it is determined that a detailed description of a related known technology may obscure the subject matter of the present invention, a detailed description thereof will be omitted.
이하, 본 발명의 구현예에 따른 항노화 조성물 및 그 제조방법에 대하여 보다 상세하게 설명한다.Hereinafter, an anti-aging composition and a method for preparing the same according to an embodiment of the present invention will be described in more detail.
본 발명에 따른 조성물은 피부 노화, 특히 열에 의한 피부 노화를 억제하기 위한 것이다. 피부에는 온도 센서의 역할을 하는 TRPV1(The transient receptor potential cation channel subfamily V member 1) 단백질이 있는데, 본 발명의 조성물에 따르면 이러한 단백질의 활성을 조절하여 열 자극에 의한 피부 손상을 방지하고, 수분 증발을 억제할 수 있다.The composition according to the invention is for suppressing skin aging, in particular skin aging due to heat. In the skin, there is a protein TRPV1 (The transient receptor potential cation channel subfamily V member 1) that acts as a temperature sensor.According to the composition of the present invention, the composition of the present invention regulates the activity of these proteins to prevent skin damage caused by thermal stimulation and evaporate moisture Can be suppressed.
본 발명에 따른 조성물은 버섯 발효물을 포함할 수 있다. 버섯 발효물에 사용되는 버섯으로는 방패버섯 속을 사용할 수 있으며, 구체적인 예로는 다발방패버섯(
Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.), 양털방패버섯(
Albatrellus ovinus (Schaeff.) Kotl. & Pouz.), 꽃방패버섯(
Albatrellus dispansus (Lloyd) Canf. & Gilb.), 초록방패버섯(
Albatrellus caeruleoporus (Peck) Pouz.), 회청색방패버섯(
Albatrellus yasudae (Lloyd) Pouzar), 긴다리방패버섯(
Albatrellus pes-caprae),
Albatrellus cristatus 및
Albatrellus ellisii으로 이루어지는 군으로부터 선택되는 하나 이상을 포함할 수 있고, 발효 또는 비발효된 것을 사용할 수 있다. 예를 들면 다발방패버섯, 양털방패버섯 또는 이들의 조합을 포함할 수 있다. 다발방패버섯 또는 양털방패버섯은 항산화, 항노화, TRPV1 활성 억제의 역할을 할 수 있다.The composition according to the present invention may include a mushroom fermented product. Mushrooms used in the mushroom fermentation can be used in the genus Shield Mushroom, and specific examples include Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.), Wool Shield Mushroom ( Albatrellus ovinus (Schaeff.) Kotl.& Pouz.), flower shield mushroom ( Albatrellus dispansus (Lloyd) Canf. & Gilb.), green shield mushroom ( Albatrellus caeruleoporus (Peck) Pouz.), gray-blue shield mushroom ( Albatrellus yasudae (Lloyd) Pouzar), long legs Shield mushrooms ( Albatrellus pes- caprae ), Albatrellus cristatus and may contain one or more selected from the group consisting of Albatrellus ellisii , fermented or non-fermented ones may be used. For example, it may include a bundle of shield mushrooms, a wool shield mushroom, or a combination thereof. Multiple shield mushrooms or woolly shield mushrooms can play a role in antioxidant, anti-aging, and inhibition of TRPV1 activity.
일구현예에 따르면, 상기 버섯 발효물은 효소 또는 효모에 의하여 발효된 것일 수 있으며, 예를 들면, 출아형 효모, 즉, 사카로미세스 세레비시아(Budding yeast;
Saccharomyces cerevisiae)에 의하여 발효된 버섯 발효물일 수 있다.According to one embodiment, the mushroom fermentation product may be fermented by enzymes or yeast, for example, germinating yeast, that is, mushrooms fermented by Saccharomyces cerevisiae (Budding yeast; Saccharomyces cerevisiae ) It may be a fermented product.
일구현예에 따르면 버섯 발효물은,According to one embodiment, the mushroom fermentation product,
방패버섯 분말에 20배 중량의 증류수를 첨가하고 혼합 및 교반하여 분말액을 제조하는 단계;Adding 20 times the weight of distilled water to the shield mushroom powder, mixing and stirring to prepare a powder solution;
상기 분말액을 110 내지 130℃에서 10 내지 20분 동안 멸균하여 열수 추출하는 단계;Sterilizing the powder solution at 110 to 130° C. for 10 to 20 minutes to extract hot water;
멸균하여 열수추출한 분말액 100중량부에 대하여, 방패버섯 에탄올 추출물 1중량부를 추가한 후, 영양배지(YM broth, BD)에서 24시간 동안 배양한 사카로미세스 세레비시아(
Saccharomyces cerevisiae)배양액을 5중량부를 접종하여 25 내지 35℃에서 60 내지 80시간 동안 발효하는 단계;To 100 parts by weight of the sterilized and hot-water-extracted powder solution, 1 part by weight of the shield mushroom ethanol extract was added, and then Saccharomyces cerevisiae cultured in a nutrient medium (YM broth, BD) for 24 hours was added to 5 Inoculating parts by weight and fermenting at 25 to 35° C. for 60 to 80 hours;
발효된 분말액을 110 내지 130℃에서 10 내지 20분 동안 멸균하는 단계; 및Sterilizing the fermented powder liquid at 110 to 130° C. for 10 to 20 minutes; And
멸균된 발효 분말액을 6000rpm으로 20분간 원심 분리 후 0.2um 필터하여 상등액을 수득하는 단계를 포함하는 방법으로 제조할 수 있다.It can be prepared by a method comprising the step of obtaining a supernatant by centrifuging the sterilized fermented powder liquid at 6000 rpm for 20 minutes and then filtering 0.2um.
본 발명에 따르면, 발효하지 않은 버섯 추출물에 비하여 올레산(oleic acid), 리놀레산(linoleic acid) 등의 지방산(fatty acid), 마그네슘(Mg), 아연(Zn), 구리(Cu)와 같은 미네랄, 그리폴린(grifolin), 폴리페놀(polyphenol), 타닌산(tannic acid) 등의 유효성분 함량이 증가된 버섯 발효물을 포함함으로써 피부의 온도를 저하시키는 동시에 수분을 보충하고 손상된 피부 장벽을 보호 및 강화할 수 있다. 그 중, 특히 그리폴린은 TRPV1(transient receptor potential cation channel subfamily V member 1)라고 불리는 온도수용체를 조절하여 피부의 온도상승에 의한 노화를 억제하고, 항염, 항암 역할을 하며 본 발명에 따른 방법으로 그리폴린을 함유하는 버섯 발효물을 제조할 수 있다.According to the present invention, compared to non-fermented mushroom extract, fatty acids such as oleic acid and linoleic acid, magnesium (Mg), zinc (Zn), minerals such as copper (Cu), and By including fermented mushrooms with an increased content of active ingredients such as grifolin, polyphenol, and tannic acid, it lowers the temperature of the skin, replenishes moisture, and protects and strengthens damaged skin barriers. . Among them, gripholine, in particular, regulates a temperature receptor called TRPV1 (transient receptor potential cation channel subfamily V member 1) to inhibit aging due to an increase in the temperature of the skin, plays an anti-inflammatory and anti-cancer role, and is thus produced by the method according to the present invention. Mushroom fermentations containing foline can be prepared.
일구현예에 따르면 상기 방패버섯 에탄올 추출물은,According to one embodiment, the shield mushroom ethanol extract,
방패버섯 분말의 10배 중량의 70% 에탄올을 첨가하는 단계;Adding 70% ethanol of 10 times the weight of the shield mushroom powder;
30 내지 50℃, 예를 들면 45℃에서 2 내지 4시간, 예를 들면 3시간 동안 교반하는 단계; 및Stirring at 30 to 50° C., eg 45° C. for 2 to 4 hours, eg 3 hours; And
6000rpm으로 20분간 원심분리 후 0.45um로 여과하는 단계; 및Centrifuging at 6000rpm for 20 minutes and then filtering with 0.45um; And
농축하여 분말로 제조하는 단계를 순차적으로 포함하는 방법으로 제조할 수 있다.It can be prepared by a method comprising the step of producing a powder by concentration in sequence.
상기 방패버섯 추출물은 방패버섯 발효물 제조 단계 중, 어느 단계에서도 첨가할 수 있으나, 예를 들면 발효초기인 균주 접종 전 단계에서 추가하는 경우 발효를 통해 폴리페놀 함량과 효능을 증가시킬 수 있다.The shield mushroom extract may be added at any stage of the manufacturing step of the shield mushroom fermentation product, but, for example, when added at the stage before strain inoculation, which is the initial stage of fermentation, the polyphenol content and efficacy may be increased through fermentation.
상기한 바와 같은 방법으로 제조된 본 발명의 조성물은 항노화 효과를 향상시킬 수 있으며, 상기 항노화 효과는 항열노화, 피부 탄력, 피부장벽 보호, 항산화, 수분 유지 및 항균으로 이루어지는 군으로부터 선택되는 하나 이상을 포함할 수 있다.The composition of the present invention prepared by the method as described above can improve the anti-aging effect, the anti-aging effect is one selected from the group consisting of anti-heat aging, skin elasticity, skin barrier protection, antioxidant, moisture retention and antibacterial It may include more than one.
이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily implement the present invention. However, the present invention may be implemented in various different forms and is not limited to the embodiments described herein.
실시예: 버섯 발효물 제조Example: Mushroom fermentation production
버섯 발효물을 제조하기 위하여 방패버섯 속 중 다발방패버섯(
Albatrellus confluens,
핀란드 수급, 분말)을 사용하였다. 다발방패버섯 분말에 그의 20배 중량에 해당하는 양의 증류수를 첨가하고 혼합 및 교반하여 분말액을 제조하였다. 분말액을 121℃에서 15분간 멸균하여 발효 전처리하였다. 멸균하여 열수추출한 분말액 100중량부에 대하여 다발방패버섯 에탄올 추출물 1중량부를 추가한 후, 영양배지(YM broth, BD)에서 24시간 동안 배양한 사카로미세스 세레비시아(
Saccharomyces cerevisiae, https://kctc.kribb.re.kr/ KCTC, 생물자원센터, KCTC 7296) 배양액을 5중량부 접종하여 30℃로 72시간 발효하였다.In order to manufacture the fermented mushrooms, Albatrellus confluens ( Albatrellus confluens , Finnish water supply, powder) was used. Distilled water in an amount corresponding to 20 times the weight of the mulberry powder was added, mixed, and stirred to prepare a powder solution. The powder was sterilized at 121° C. for 15 minutes to pre-ferment. After adding 1 part by weight of ethanol extract of mulberry mushroom to 100 parts by weight of sterilized and hot water-extracted powder, Saccharomyces cerevisiae cultured for 24 hours in a nutrient medium (YM broth, BD), https:/ /kctc.kribb.re.kr/ KCTC, Center for Biological Resources, KCTC 7296) 5 parts by weight of the culture solution was inoculated and fermented at 30°C for 72 hours.
상기 다발방패버섯 에탄올 추출물은 다발방패버섯 분말의 10배 중량의 70% 에탄올을 첨가하여 45℃에서 3시간 동안 교반하고, 6000rpm으로 20분간 원심분리 후 0.45um로 여과하고, 여과한 다발방패버섯 에탄올 추출물을 농축하여 분말로 제조하였다.The mulberry ethanol extract was added with 70% ethanol of 10 times the weight of the mulberry powder, stirred at 45° C. for 3 hours, centrifuged at 6000 rpm for 20 minutes, filtered with 0.45 um, filtered mulberry ethanol The extract was concentrated to prepare a powder.
발효된 분말액을 121℃에서 15분간 멸균하고, 6000rpm으로 20분간 원심 분리 후 0.2um로 여과하여 버섯 발효물인 상등액을 수득하였다.The fermented powder was sterilized at 121° C. for 15 minutes, centrifuged at 6000 rpm for 20 minutes, and then filtered with 0.2 μm to obtain a supernatant as a fermented mushroom.
수득된 버섯 발효물의 물성은 다음과 같다.The properties of the obtained fermented mushroom are as follows.
성상: 액체Appearance: Liquid
색: 밝은 갈색 또는 갈색Color: light brown or brown
향: 특유의 냄새Fragrance: A characteristic smell
비중(specific gravity) (d20/20): 1.000~1.040Specific gravity (d20/20): 1.000~1.040
pH (25℃) : 5.64±1pH (25℃): 5.64±1
굴절률(refractive index) (n20/D): 1.3000~1.4000Refractive index (n20/D): 1.3000-1.4000
총 미생물 수(total microorganism count): < 100 CFU/gTotal microorganism count: <100 CFU/g
비교예: 버섯 추출물 제조Comparative Example: Preparation of mushroom extract
버섯 추출물을 제조하기 위하여 다발방패버섯(
Albatrellus confluens, 핀란드 수급, 분말)에 그의 20배 중량에 해당하는 양의 증류수를 넣고 혼합 및 교반하여 분말액을 제조하였다. 분말액을 121℃에서 15분간 멸균한 열수추출물에 실시예와 동일한 방법으로 제조한 다발방패버섯 70% 에탄올 추출물 1%를 추가한 분말액을 6000rpm으로 20분간 원심 분리 후 0.2um로 여과하여 방패버섯 추출물을 제조하였다.In order to prepare a mushroom extract, distilled water in an amount corresponding to 20 times the weight thereof was added to Albatrellus confluens (Finnish water supply, powder), and mixed and stirred to prepare a powder solution. The powder solution was centrifuged at 6000 rpm for 20 minutes and filtered with 0.2 μm after centrifugation at 6000 rpm for 20 minutes by adding 1% of 70% ethanol extract prepared in the same manner to the hot water extract sterilized at 121°C for 15 minutes. The extract was prepared.
실험예 1: 폴리페놀 함량Experimental Example 1: Polyphenol content
비교예에 따른 다발방패버섯 추출물(
Albatrellus confluens extract)과 실시예에 따른 다발방패버섯 발효물(
Albatrellus confluens ferment extract) 각각의 총 폴리페놀(total polyphenol) 함량을 비교하기 위하여 Folin&Ciocalteu's phenol 시약을 이용하여 정량하였다. 표준물질로는 갈릭산(gallic acid)를 사용하였다. 시료와 표준물질을 50% Folin&Ciocalteu's phenol과 4:1 비율로 혼합하여 상온에 5분간 반응시킨 뒤, 2% Na
2CO
3 용액 동량을 첨가하여 상온에 30분간 반응시켰다. 표준 물질은 100, 80, 60, 40, 20ug/ml 농도로 사용하고 각각의 흡광도를 추후 standard curve를 그리는데 사용하였다. 반응 후, 흡광도 측정 기기 Multiskan GO(Thermo Fisher Scientific)를 이용하여 750 nm에서 흡광도를 측정하고, 표준 물질의 흡광도 값에 대비하여 발효 전, 후의 Total polyphenol 양을 비교하였다. 그 결과는 도 1에 나타내었으며, 도 1에 나타난 바와 같이 본 발명에 포함되는 버섯 발효물은 발효하지 않은 발효 추출물에 비하여 총 폴리페놀의 함량이 약 25% 증가한 것을 확인할 수 있다.Quantification using Folin&Ciocalteu's phenol reagent to compare the total polyphenol content of each of the Albatrellus confluens extract according to the comparative example and the Albatrellus confluens ferment extract according to the example. I did. As a standard material, gallic acid was used. The sample and the standard were mixed with 50% Folin&Ciocalteu's phenol in a 4:1 ratio and reacted at room temperature for 5 minutes, and then an equal amount of 2% Na 2 CO 3 solution was added and reacted at room temperature for 30 minutes. Standard substances were used at concentrations of 100, 80, 60, 40, and 20ug/ml, and each absorbance was used to draw a standard curve later. After the reaction, the absorbance was measured at 750 nm using the absorbance measuring instrument Multiskan GO (Thermo Fisher Scientific), and the amount of total polyphenol before and after fermentation was compared with the absorbance value of the standard material. The results are shown in Fig. 1, and as shown in Fig. 1, it can be seen that the mushroom fermented product included in the present invention has a total polyphenol content increased by about 25% compared to the non-fermented fermented extract.
실험예 2: 항산화 분석Experimental Example 2: Antioxidant Analysis
비교예에 따른 다발방패버섯 추출물(
Albatrellus confluens extract)과 실시예에 따른 다발방패버섯 발효물(
Albatrellus confluens ferment extract)의 항산과 효과를 확인하기 위하여 DPPH(2,2-diphenyl-1-picryl hydrezyl) 라디칼 소거능 분석을 실시하였다. 1 mM DPPH 용액을 메탄올에 녹여 즉시 사용하였다. 시료 용액과 DPPH 용액을 1:1로 혼합하여, 상온 암소에 20 분간 방치하였다. 이때 양성 대조군(positive control)로 아스코르브산(ascorbic acid) 0.1 mg/ml을 사용하였다. 20분 방지 후, 흡광도 측정 기기 Multiskan GO(Thermo Fisher Scientific) 를 이용하여 540nm에서 흡광도를 측정하였다. 대조군(control)대비 라디컬 율(%)를 산출하였다. 그 결과는 도 2에 나타내었으며, 그래프에 나타난 바와 같이 다발방패버섯발효물(
Albatrellus confluens ferment extract)의 항산화 효능이 발효 전 시료에 비해 높아진 것을 확인할 수 있으며, 특히 발효물 1000ug/ml의 농도에서 약 80%의 자유라디칼 소거능을 나타내는 것을 확인하였다.DPPH (2,2-diphenyl-1-picryl hydrezyl) to confirm the antioxidant and effect of the Albatrellus confluens extract according to the comparative example and the Albatrellus confluens ferment extract according to the example Radical scavenging ability analysis was performed. 1 mM DPPH solution was dissolved in methanol and used immediately. The sample solution and the DPPH solution were mixed at a ratio of 1:1, and left in the dark at room temperature for 20 minutes. At this time, 0.1 mg/ml of ascorbic acid was used as a positive control. After 20 minutes of prevention, absorbance was measured at 540 nm using an absorbance measuring instrument Multiskan GO (Thermo Fisher Scientific). The radical ratio (%) compared to the control group (control) was calculated. The results are shown in Fig. 2, and as shown in the graph, it can be seen that the antioxidant efficacy of Albatrellus confluens ferment extract is higher than that of the sample before fermentation, especially at a concentration of 1000 ug/ml of the fermented product. It was confirmed that 80% of the free radical scavenging ability was shown.
실험예 3: 세포독성Experimental Example 3: Cytotoxicity
비교예에 따른 다발방패버섯 추출물(
Albatrellus confluens extract)과 실시예에 따른 다발방패버섯 발효물(
Albatrellus confluens ferment extract)의 세포독성을 확인하기 위해서 HaCaT 각질세포의 증식에 미치는 영향을 시험하였으며, 배양된 HaCaT 각질세포에 다발방패버섯 발효물(
Albatrellus confluens ferment extract), 다발방패버섯 추출물(
Albatrellus confluens extract)을 각각의 농도로 처리한 후, 세포 생존율을 측정하였다. MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 시약을 사용하여 측정하였으며, MTT는 세포 내로 흡수되어 미토콘드리아에서 숙신산탈수효소에 의해 포르마잔을 형성하는데, 이 물질의 세포 내 축적은 미토콘드리아의 활성, 넓게는 세포의 활성을 의미하므로 세포의 독성 평가를 할 수 있다.To confirm the cytotoxicity of the Albatrellus confluens extract according to the comparative example and the Albatrellus confluens ferment extract according to the example, the effect on the proliferation of HaCaT keratinocytes was tested, and the cultured HaCaT keratinocytes were treated with Albatrellus confluens ferment extract and Albatrellus confluens extract at respective concentrations, and then cell viability was measured. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was measured using a reagent, and MTT was absorbed into cells to form formazan by succinate dehydratase in mitochondria. Accumulation of substances in cells means mitochondrial activity, broadly, cellular activity, so the toxicity of cells can be evaluated.
96 well plate에 각각의 셀을 2 X 10
4 cells/well로 분주한 뒤, 24시간 세포 배양기에 배양하였다. 배양 후, 1% FBS를 포함하는 배지로 배지를 교체하여 기아상태(starvation)로 만들어 24시간 배양하였다. 다발방패버섯 추출물(
Albatrellus confluens extract), 다발방패버섯 발효물(
Albatrellus
confluens ferment extract)를 각각의 농도로 처리하여 24시간 배양한 후, MTT solution을 처리하고 4시간 배양하였다. 배양 후, 배지를 제거하고 DMSO(dimethyl sulfoxide)로 세포를 완전히 녹인 후, 흡광도 측정 기기 Multiskan GO(Thermo Fisher Scientific)로 450 nm에서 흡광도를 측정하였다. 결과를 바탕으로 아래의 세포생존율을 산출식을 통해 세포의 생존율을 시료를 처리하지 않은 군과 비교하여 %로 나타내었다.Each cell was aliquoted into a 96 well plate at 2 X 10 4 cells/well and cultured in a cell incubator for 24 hours. After cultivation, the medium was replaced with a medium containing 1% FBS, resulting in starvation and cultured for 24 hours. Albatrellus confluens extract and Albatrellus confluens ferment extract were treated at respective concentrations and cultured for 24 hours, followed by treatment with MTT solution and cultured for 4 hours. After cultivation, the medium was removed and the cells were completely dissolved with dimethyl sulfoxide (DMSO), and absorbance was measured at 450 nm with an absorbance measuring instrument Multiskan GO (Thermo Fisher Scientific). Based on the results, the cell viability was expressed as% by comparing the cell viability with the group not treated with the sample through the formula for calculating the cell viability below.
세포 생존율(%) = [시료첨가군의 흡광도 (450 nm) / 시료 무첨가군의 흡광도 (450 nm)] × 100Cell viability (%) = [absorbance of the sample added group (450 nm) / absorbance of the sample-free group (450 nm)] × 100
그 결과는 도 3에 나타내었다. HaCaT 각질세포에 대한 다발방패버섯추출물(
Albatrellus confluens extract), 다발방패버섯발효물(
Albatrellus
confluens ferment extract)의 독성을 나타내지 않는 농도를 확인하였다. 추후 실험에 독성 결과를 바탕으로 시료의 농도를 결정하였다. 도 3의 그래프에 나타난 바와 같이, 발효물은 HaCaT 세포에 대하여 250ug/ml 농도 이하에서 세포 독성을 나타내지 않는 것을 확인할 수 있다.The results are shown in FIG. 3. HaCaT were identified which does not exhibit the toxic concentration of the bundle shield mushroom extract on keratinocytes (Albatrellus confluens extract), the bundle shield mushroom fermentation (Albatrellus confluens ferment extract). In a later experiment, the concentration of the sample was determined based on the toxicity result. As shown in the graph of FIG. 3, it can be seen that the fermented product does not exhibit cytotoxicity at a concentration of 250 ug/ml or less for HaCaT cells.
실험예 4: 칼슘 유입Experimental Example 4: Calcium inflow
열 또는 화학적 자극의 감지에 의하여 TRPV1 이 활성화되어 칼슘(Ca
2+)의 세포 내 유입이 유도되며, 이로 인하여 세포의 노화가 유도되므로 칼슘의 유입을 확인함으로써 세포의 노화 정도를 확인하였다.TRPV1 is activated by the detection of thermal or chemical stimulation to induce the influx of calcium (Ca 2+ ) into the cell, which induces cell senescence. Therefore, the degree of cell aging was confirmed by checking the influx of calcium.
다발방패버섯발효물(
Albatrellus
confluens ferment extract)과 다발방패버섯추출물(
Albatrellus
confluens extract)이 세포 내 칼슘이온 유입을 억제하는지를 확인하기 위해 칼슘이온을 형광으로 염색하여 그 양의 변화를 시각적으로 확인하였다. 42℃ 이상의 온도, 캡사이신(capsaicin), 산성 조건과 같은 자극에 의해서 TRPV1(The transient receptor potential cation channel, subfamily V, member 1)이 활성화 되면 세포 외부의 칼슘이온이 세포 내부로 이동한다. 세포 내 칼슘이온 변화를 확인함으로써 TRPV1의 활성 정도를 확인할 수 있다.To confirm whether the Albatrellus confluens ferment extract and Albatrellus confluens extract inhibit the influx of calcium ions into the cells, calcium ions were stained with fluorescence to visually check the change in the amount. When TRPV1 (The transient receptor potential cation channel, subfamily V, member 1) is activated by stimulation such as temperature above 42℃, capsaicin, and acidic conditions, calcium ions from the outside of the cell move inside the cell. The degree of activity of TRPV1 can be confirmed by checking the change in calcium ion in the cell.
96 well plate에 각각의 셀을 1 X 10
4 cells/well로 분주한 뒤, 24시간 세포 배양기에 배양하였다. 배양 후, 1% FBS를 포함하는 배지로 배지를 교체하여 기아상태(Starvation)로 만들어 24시간 배양하였다. 다발방패버섯발효물(
Albatrellus confluens ferment extract)과 다발방패버섯추출물(
Albatrellus
confluens extract)을 농도에 맞게 처리한 후, 30분 배양하였다. 이때 대조군으로 5μM 캡사제핀(Capsazepine)을 사용하였다. Calcium Kit; Fluo-8 No wash Calcium Assay Kit(abcam)을 사용하여 loading solution을 처리하고 암 조건에서 37℃에서 30분, 실온에서 30분 배양하였다. 5 μM 캡사이신(capsaicin)을 처리하고 즉시 Cytell 기기로 세포 사진을 촬영하고 세포 내 칼슘이온 변화량을 확인하였다. 그 결과는 도 4에 나타내었으며, 캡사이신 자극에 의한 칼슘이온(calcium ion)의 세포 내 유입이 다발방패버섯 발효물에 의하여 억제된 것을 확인할 수 있다.Each cell was aliquoted into a 96 well plate at 1 X 10 4 cells/well and incubated in a cell incubator for 24 hours. After cultivation, the medium was replaced with a medium containing 1% FBS, resulting in starvation and cultured for 24 hours. Albatrellus confluens ferment extract and Albatrellus confluens extract were treated according to the concentration and incubated for 30 minutes. At this time, 5 μM capsazepine was used as a control. Calcium Kit; The loading solution was treated with Fluo-8 No wash Calcium Assay Kit (abcam), and incubated for 30 minutes at 37°C and 30 minutes at room temperature in dark conditions. After treatment with 5 μM capsaicin, cells were immediately photographed with a Cytell device, and the amount of calcium ion change in the cells was checked. The results are shown in Fig. 4, and it can be seen that the influx of calcium ions into the cells due to capsaicin stimulation was suppressed by the fermented mulberry mushroom.
실험예 5: TRPV1 및 MMP-1 발현Experimental Example 5: TRPV1 and MMP-1 expression
다발방패버섯발효물(
Albatrellus
confluens ferment extract)과 다발방패버섯추출물(
Albatrellus confluens extract)이 TRPV1(The transient receptor potential cation channel, subfamily V, member 1)과 MMP-1(Matrix metalloproteinase-1)의 mRNA 발현량을 조절하는지를 확인하는 실험을 진행하였다. 6 well plate에 1 X 10
6 cells/well로 분주한 뒤, 24시간 세포 배양기에 배양하였다. 배양 후, 1% FBS를 포함하는 배지로 배지를 교체하여 기아상태(Starvation)로 만들어 24시간 배양하였다. 다발방패버섯발효물(
Albatrellus
confluens ferment extract)과 다발방패버섯추출물(
Albatrellus
confluens extract)을 농도에 맞게 처리한 후, 30분 배양하였다. 이때 대조군으로 5 μM 캡사제핀(Capsazepine)을 사용하였다. 10 μM 캡사이신(capsaicin)을 처리하고, 24시간 배양하였다. 배지를 제거하고 RNA extract kit(TaKaRa MiniBest RNA Extraction Kit)를 사용하여 RNA를 추출하고, Qubit Fluorometer (Qubit 2.0 Fluorometer, life technologies)를 이용하여 RNA를 정량하였다. High-Capacity RNA-to-cDNA kit(applied biosystems)를 이용하여 동일한 양의 RNA로 cDNA를 합성하였다. Taqman primer TRPV1, MMP-1, GAPDH는 life technologies사에서 구입해서 사용하였다. Taqman master mix를 하용하여 Real time PCR 장비 Step One Plus Real-Time PCR(Applied Biosystem)를 이용하여 원하는 유전자(gene)를 증폭하여 유전자 발현량의 변화를 확인하였다. MMP-1 유전자 발현량의 확인 결과는 도 5에 나타내었고, TRPV1 유전자 발현량의 확인 결과는 도 6에 나타내었다. 도 5 및 6에 나타난 바와 같이, 다발방패버섯발효물(
Albatrellus
confluens ferment extract)이 캡사이신(capsaicin)에 의해 활성화된 TRPV1 및 MMP-1의 mRNA 발현을 억제하는 것을 확인할 수 있다. Albatrellus confluens ferment extract and Albatrellus confluens extract express mRNA of TRPV1 (The transient receptor potential cation channel, subfamily V, member 1) and MMP-1 (Matrix metalloproteinase-1). An experiment was conducted to check whether the amount was controlled. After dispensing 1 X 10 6 cells/well into a 6 well plate, it was cultured in a cell incubator for 24 hours. After cultivation, the medium was replaced with a medium containing 1% FBS, resulting in starvation and cultured for 24 hours. Albatrellus confluens ferment extract and Albatrellus confluens extract were treated according to the concentration and incubated for 30 minutes. At this time, 5 μM capsazepine was used as a control. 10 μM capsaicin was treated, and cultured for 24 hours. The medium was removed, RNA was extracted using an RNA extract kit (TaKaRa MiniBest RNA Extraction Kit), and RNA was quantified using a Qubit Fluorometer (Qubit 2.0 Fluorometer, life technologies). CDNA was synthesized with the same amount of RNA using a High-Capacity RNA-to-cDNA kit (applied biosystems). Taqman primers TRPV1, MMP-1, and GAPDH were purchased and used from life technologies. Using the Taqman master mix, a desired gene was amplified using Real-time PCR equipment Step One Plus Real-Time PCR (Applied Biosystem), and the change in gene expression level was confirmed. The results of confirming the expression level of the MMP-1 gene are shown in FIG. 5, and the results of confirming the expression level of the TRPV1 gene are shown in FIG. As shown in Figures 5 and 6, it can be seen that the multi-shield mushroom fermentation product ( Albatrellus confluens ferment extract) inhibits the mRNA expression of TRPV1 and MMP-1 activated by capsaicin.
실험예 6: 피부 온도 저하Experimental Example 6: Lowering the skin temperature
21명의 피험자를 선정하여 시험자가 다발방패버섯 발효물(
Albatrellus
confluens ferment extract)을 포함하는 크림을 안면부 시험 부위에 일회 도포한 후 열화상 카메라를 이용하여 피부 온도의 즉각적인 변화를 분석하였다. 다발방패버섯 발효물(
Albatrellus
confluens ferment extract)을 포함하는 크림을 사용하였을 때, 이를 포함하지 않는 크림을 사용하였을 때보다 통계적으로 유의한 수준으로 피부 온도가 감소하는 것을 확인하였다. 구체적으로 도 7에 실시예에 따른 다발방패버섯 발효물을 포함하는 크림의 도포 전, 후 각질층 온도 변화량을 나타내었으며, 그래프에서 확인할 수 있는 바와 같이, 시험부위에서 평균 2.63℃ 피부 온도 저하 효과를 나타냄을 알 수 있다. 또한, 도 8에 열화상 카메라 측정 사진을 나타내었으며, 실시예에 따른 발효물을 도포한 시험 부위인 좌측 볼의 온도 변화를 확인할 수 있다.Twenty-one subjects were selected, and the tester applied a cream containing Albatrellus confluens ferment extract once to the facial area, and then analyzed the immediate change in skin temperature using a thermal imaging camera. When a cream containing Albatrellus confluens ferment extract was used, it was confirmed that the skin temperature decreased to a statistically significant level compared to when a cream containing no cream was used. Specifically, FIG. 7 shows the amount of change in the temperature of the stratum corneum before and after the application of the cream containing the fermented mulberry mushroom according to the embodiment, and as can be seen from the graph, an average 2.63°C skin temperature reduction effect at the test site is shown. Can be seen. In addition, a measurement photograph of the thermal imaging camera is shown in FIG. 8, and a temperature change of the left cheek, which is a test area to which the fermentation product according to the embodiment is applied, can be confirmed.
상기의 결과로부터 다발방패버섯 발효물(
Albatrellus
confluens ferment extract)이 즉각적인 피부 온도 저하(쿨링) 효과를 가지는 것을 확인하였다.From the above results, it was confirmed that the Albatrellus confluens ferment extract had an immediate skin temperature reduction (cooling) effect.
실험예 7: 그리폴린(Grifolin)Experimental Example 7: Grifolin
실시예에 따른 다발방패버섯 발효물(
Albatrellus
confluens ferment extract)에 대하여 고성능 액체 크로마토그래피(high-performance liquid chromatography, HPLC) 분석으로 그리폴린(grifolin)을 확인하였다.Examples of high-performance liquid chromatography so morpholine (grifolin) analysis (high-performance liquid chromatography, HPLC ) with respect to the bundle shield mushroom fermentation (Albatrellus confluens ferment extract) was confirmed in accordance with the.
분석 조건은 다음과 같다.Analysis conditions are as follows.
Girfolin의 HPLC 분석 조건HPLC analysis conditions of Girfolin
Instrument: Waters 2695 & 996Instrument: Waters 2695 & 996
Detection: UV 213nmDetection: UV 213nm
Column: Agilent Eclipse XDB-C18, 5μm, 4.6 x 150 mmColumn: Agilent Eclipse XDB-C18, 5μm, 4.6 x 150 mm
Column Temp.: 25℃Column Temp.: 25℃
Mobile phase: Acetonitrile 75%:0.01% phosphoric acid in DW 25%Mobile phase: Acetonitrile 75%:0.01% phosphoric acid in DW 25%
Flow rate: 1.0 mL/minFlow rate: 1.0 mL/min
Injection: 20 μLInjection: 20 μL
그리폴린의 스탠다드 분석 피크는 도 9에 나타내었고, 다발방패버섯 발효물(Albatrellus ovinus ferment extract)의 결과는 도 10에 나타내었다.The standard analysis peak of gripholine is shown in Fig. 9, and the results of the multi-leaf mushroom ferment (Albatrellus ovinus ferment extract) are shown in Fig. 10.
도 9 및 10으로부터 확인할 수 있는 바와 같이, 본 발명에 따른 버섯 발효물은 그리폴린을 함유하고 있음을 확인하였다.As can be seen from FIGS. 9 and 10, it was confirmed that the mushroom fermented product according to the present invention contained gripholine.
상기 결과에서 확인할 수 있는 바와 같이, 본 발명에 따르면 그리폴린 및 폴리페놀과 같은 유효성분을 함유한 조성물을 수득할 수 있고, 세포 독성이 없이 항산화 효능을 향상시킬 수 있으며, 칼슘 이온의 세포 내 유입을 억제함으로써 TRPV1 및 MMP-1의 활성을 저해하여 피부 노화 및 탄력 저하를 방지할 수 있고, 즉각적 피부 온도 저하 효과를 향상시킴으로써 피부 노화를 더욱 효과적으로 억제할 수 있다.As can be seen from the above results, according to the present invention, a composition containing active ingredients such as griffoline and polyphenol can be obtained, antioxidant efficacy can be improved without cytotoxicity, and calcium ions can enter cells By inhibiting the activity of TRPV1 and MMP-1, it is possible to prevent skin aging and loss of elasticity, and by improving the immediate skin temperature reduction effect, skin aging can be more effectively suppressed.
이상의 설명은 본 발명의 기술 사상을 예시적으로 설명한 것에 불과한 것으로서, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자라면 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 다양한 수정 및 변형이 가능하다. 또한, 본 발명에 개시된 실시 예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시 예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The above description is merely illustrative of the technical idea of the present invention, and those of ordinary skill in the technical field to which the present invention pertains can make various modifications and variations without departing from the essential characteristics of the present invention. In addition, the embodiments disclosed in the present invention are not intended to limit the technical idea of the present invention, but to explain the technical idea, and the scope of the technical idea of the present invention is not limited by these embodiments. The scope of protection of the present invention should be interpreted by the following claims, and all technical ideas within the scope equivalent thereto should be interpreted as being included in the scope of the present invention.
Claims (7)
- 다발방패버섯 분말에 20배 중량의 증류수를 첨가하고 혼합 및 교반하여 분말액을 제조하는 단계;Adding 20 times the weight of distilled water to the mulberry powder, mixing and stirring to prepare a powder solution;상기 분말액을 110 내지 130℃에서 10 내지 20분 동안 멸균하여 열수추출하는 단계;Sterilizing the powder solution at 110 to 130° C. for 10 to 20 minutes to extract hot water;멸균하여 열수추출한 분말액 100중량부에 대하여, 다발방패버섯 에탄올 추출물 1중량부를 추가하고, 영양배지(YM broth, BD)에서 24시간 동안 배양한 사카로미세스 세레비시아( Saccharomyces cerevisiae, 생물자원센터, KCTC 7296) 5중량부를 접종하여 25 내지 35℃에서 60 내지 80시간 동안 발효하는 단계;To 100 parts by weight of sterilized and hot water-extracted powder solution, 1 part by weight of ethanol extract of mulberry mushroom was added, and Saccharomyces cerevisiae cultured in a nutrient medium (YM broth, BD) for 24 hours ( Saccharomyces cerevisiae , Center for Biological Resources) , KCTC 7296) 5 parts by weight of inoculation and fermentation at 25 to 35°C for 60 to 80 hours;발효된 분말액을 110 내지 130℃에서 10 내지 20분 동안 멸균하는 단계; 및Sterilizing the fermented powder liquid at 110 to 130° C. for 10 to 20 minutes; And멸균된 발효 분말액을 원심분리 및 필터하여 상등액을 수득하는 단계를 포함하는 다발방패버섯 발효물을 포함하는 항노화 조성물의 제조방법.A method for producing an anti-aging composition comprising a fermented mulberry mushroom comprising the step of centrifuging and filtering the sterilized fermented powder liquid to obtain a supernatant.
- 제1항에 있어서,The method of claim 1,상기 조성물이 발효 또는 비발효된 양털방패버섯( Albatrellus ovinus (Schaeff.) Kotl. & Pouz.), 꽃방패버섯( Albatrellus dispansus (Lloyd) Canf. & Gilb.), 초록방패버섯( Albatrellus caeruleoporus (Peck) Pouz.), 회청색방패버섯( Albatrellus yasudae (Lloyd) Pouzar), 긴다리방패버섯( Albatrellus pes-caprae), Albatrellus cristatus 및 Albatrellus ellisii으로 이루어지는 군으로부터 선택되는 하나 이상의 추출물을 더 포함하는 것인, 항노화 조성물의 제조방법.The composition is fermented or non-fermented woolly shield mushroom ( Albatrellus ovinus (Schaeff.) Kotl. & Pouz.), flower shield mushroom ( Albatrellus dispansus (Lloyd) Canf. & Gilb.), green shield mushroom ( Albatrellus caeruleoporus (Peck)) Pouz.), gray-blue shield mushroom ( Albatrellus yasudae (Lloyd) Pouzar), long legs shield mushroom ( Albatrellus pes- caprae), Albatrellus cristatus and Albatrellus ellisii , which further comprises one or more extracts selected from the group consisting of, anti-aging Method of making the composition.
- 제1항에 있어서 상기 다발방패버섯 에탄올 추출물이,The method of claim 1, wherein the ethanol extract of mulberry mushroom,방패버섯 분말의 10배 중량의 70% 에탄올을 첨가하는 단계;Adding 70% ethanol of 10 times the weight of the shield mushroom powder;30 내지 50℃에서 2 내지 4시간 동안 교반하는 단계;Stirring for 2 to 4 hours at 30 to 50 ℃;6000rpm으로 20분간 원심분리 후 0.45um로 여과하는 단계; 및Centrifuging at 6000rpm for 20 minutes and then filtering with 0.45um; And농축하여 분말로 제조하는 단계를 순차적으로 포함하는 방법으로 제조되는 것인, 항노화 조성물의 제조방법.The method for producing an anti-aging composition, which is produced by a method comprising the step of producing a powder by concentration.
- 제1항에 있어서,The method of claim 1,상기 항노화가 항열노화, 피부 탄력, 피부장벽 보호, 항산화, 수분 유지 및 항균으로 이루어지는 군으로부터 선택되는 하나 이상의 용도를 포함하는 것인, 항노화 조성물의 제조방법.The method for producing an anti-aging composition, wherein the anti-aging includes one or more uses selected from the group consisting of anti-heat aging, skin elasticity, skin barrier protection, antioxidant, moisture retention and antibacterial.
- 제1항 내지 제4항 중 어느 한 항에 따른 제조방법으로 제조되는 항노화 조성물.An anti-aging composition prepared by the manufacturing method according to any one of claims 1 to 4.
- 제5항에 따른 항노화 조성물을 함유하는 화장료 조성물.A cosmetic composition containing the anti-aging composition according to claim 5.
- 제5항에 따른 항노화 조성물을 함유하는 건강 기능성 식품 조성물.A health functional food composition containing the anti-aging composition according to claim 5.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190072250A KR102022408B1 (en) | 2019-06-18 | 2019-06-18 | Anti-aging composition comprising fermented albatrellus confluens products |
KR10-2019-0072250 | 2019-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020256297A1 true WO2020256297A1 (en) | 2020-12-24 |
Family
ID=68730664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2020/006778 WO2020256297A1 (en) | 2019-06-18 | 2020-05-26 | Anti-aging composition comprising albatrellus confluens, and preparation method for same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102022408B1 (en) |
WO (1) | WO2020256297A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102519369B1 (en) * | 2020-09-22 | 2023-04-25 | 코스맥스 주식회사 | Cooling cosmetic composition for preventing of skin heat aging and improving of pores |
KR102659309B1 (en) * | 2023-03-28 | 2024-05-03 | 주식회사 마노파레 | Cosmetic composition for improvement of skin itching by dry skin or atopic dermatitis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249710A (en) * | 1988-05-20 | 1990-02-20 | Narisu Keshohin:Kk | Cosmetic |
KR20080036315A (en) * | 2006-10-23 | 2008-04-28 | 주식회사 두산 | Fermented products of phellinus linteus by lactic acid bacteria and preparation method thereof |
KR20120087408A (en) * | 2011-01-28 | 2012-08-07 | 조선대학교산학협력단 | Composition for antioxidation effect comprising sparassis crispa extract |
KR20150099457A (en) * | 2014-02-20 | 2015-08-31 | 순천대학교 산학협력단 | Cosmetic composition comprising fermented Phellinus linteus extract |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6116145B2 (en) * | 2012-06-26 | 2017-04-19 | ゲオール化学株式会社 | Mushroom culture composition |
CN107793489A (en) * | 2016-09-05 | 2018-03-13 | 凌建亚 | A kind of method that polysaccharide grifolin is extracted from grifola frondosus |
-
2019
- 2019-06-18 KR KR1020190072250A patent/KR102022408B1/en active
-
2020
- 2020-05-26 WO PCT/KR2020/006778 patent/WO2020256297A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249710A (en) * | 1988-05-20 | 1990-02-20 | Narisu Keshohin:Kk | Cosmetic |
KR20080036315A (en) * | 2006-10-23 | 2008-04-28 | 주식회사 두산 | Fermented products of phellinus linteus by lactic acid bacteria and preparation method thereof |
KR20120087408A (en) * | 2011-01-28 | 2012-08-07 | 조선대학교산학협력단 | Composition for antioxidation effect comprising sparassis crispa extract |
KR20150099457A (en) * | 2014-02-20 | 2015-08-31 | 순천대학교 산학협력단 | Cosmetic composition comprising fermented Phellinus linteus extract |
Non-Patent Citations (1)
Title |
---|
HWANG YU-YEON; CHONG MYONG-SOO; KIM HAE-JA; LEE KI-NAM: "Studies on the Polysaccharide of Ganoderma lucidium Extract by Microorganism Fermentation", KOREAN JOURNAL OF ORIENTAL PHYSIOLOGY & PATHOLOGY, vol. 21, no. 6, 2007, pages 1506 - 1512, XP053004675 * |
Also Published As
Publication number | Publication date |
---|---|
KR102022408B1 (en) | 2019-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020256297A1 (en) | Anti-aging composition comprising albatrellus confluens, and preparation method for same | |
KR102119825B1 (en) | A cosmetic composition for maintaining the balance of microbiom in the skin comprising brown rice, grean tea and dandelion fermentation extracts and methode thereof | |
WO2021060870A1 (en) | Cosmetic composition containing fermentation product of sprout ginseng, and preparation method therefor | |
KR102152878B1 (en) | Lactobacillus pentosus strain and composition for improving microbial flora and improving skin varrier comprising the same | |
IT202000003233A1 (en) | BACTERIAL STRAIN AND ITS MEDICAL USES | |
WO2020218888A1 (en) | Cosmetic composition for skin whitening containing novel lactobacillus rhamnosus lm1011 as active ingredient | |
WO2017142330A1 (en) | Whitening cosmetic composition comprising persimmon extract fraction as active ingredient | |
WO2021060656A1 (en) | Staphylococcus gallinarum st-4 strain, and use thereof for improving skin condition | |
WO2015163589A1 (en) | Cosmetic composition containing mentha haplocalyx as active ingredient | |
Nciki et al. | Mezoneuron benthamianum inhibits cell adherence, hyphae formation, and phospholipase production in Candida albicans | |
KR20120092229A (en) | Cosmetic composition comprising the fermented extracts of tissue cultures of brassica napus l, punica granatum and panax ginseng) | |
WO2021060652A1 (en) | Staphylococcus haemolyticus strain st-8 and use thereof for improving condition of skin | |
WO2021060658A1 (en) | Staphylococcus lentus st-2 strain and use thereof for skin condition improvement | |
KR20140062564A (en) | Cosmetic composition including hemolymph from silkworm larvae | |
CN116918701A (en) | Callus culture medium and extract of rosa tenuifolia, preparation method and application | |
WO2017171404A1 (en) | Composition for skin moisturization or skin whitening, containing pentacyclic triterpene caffeic acid esters | |
WO2021241796A1 (en) | Cosmetic composition and method for producing same | |
CN110893169A (en) | Whitening and moisturizing mask and preparation method thereof | |
WO2022119074A1 (en) | Method for preparing cosmetic composition comprising fermented fig alcohol extract, and cosmetic composition prepared thereby | |
KR101667542B1 (en) | Cosmetic composition including fermentation product from silkworm larvae hemolymph | |
WO2010013885A1 (en) | Cosmetic composition containing salt-fermented extract of natural materials | |
KR101583052B1 (en) | Anti-wrinkle cosmetic composition containing Polygonum multiflorum extract | |
WO2018052152A1 (en) | Antiaging composition for external preparation for skin, containing extract of germinated glycine gracilis as active ingredient | |
CN116650380B (en) | Anti-aging tea fermentation product for improving skin microcirculation and preparation method and application thereof | |
KR20140147913A (en) | cosmetic composition including 70kDa protein from silkworm larvae hemolymph |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20827019 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20827019 Country of ref document: EP Kind code of ref document: A1 |